tiprankstipranks
Trending News
More News >
Takara Holdings Inc. (JP:2531)
:2531
Japanese Market

Takara Holdings Inc. (2531) AI Stock Analysis

Compare
0 Followers

Top Page

JP:2531

Takara Holdings Inc.

(2531)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 5.2)
Rating:61Neutral
Price Target:
¥1,701.00
▲(5.85% Upside)
Action:DowngradedDate:11/12/25
Takara Holdings Inc. has a solid financial foundation with strong revenue growth and a robust balance sheet. However, bearish technical indicators and moderate valuation concerns weigh on the overall score. Improving cash flow management and addressing liquidity challenges are crucial for enhancing the stock's attractiveness.
Positive Factors
Consistent revenue growth
Sustained top-line growth indicates rising demand for Takara's beverage portfolio and effective channel execution. Over multiple years this improves scale economics, funds brand investment and marketing, and helps absorb fixed costs—supporting durable cash generation and competitive positioning.
Robust balance sheet
A healthy equity ratio and manageable leverage provide financial resilience, reduce refinancing risk and preserve capacity for strategic spending. Growing stockholders' equity and assets enhance borrowing optionality and support medium-term investments, dividends or opportunistic M&A without immediate distress.
Operational efficiency & cash generation
Stable gross and net margins combined with strong operating cash flow to net income signal efficient production, pricing and working-capital management. That underlying efficiency supports sustainable profitability, funds reinvestment in brands/channels, and underpins long-term free cash flow potential if capex is managed.
Negative Factors
Negative free cash flow (capex-driven)
Persistent negative free cash flow from elevated capital spending reduces cash available for debt repayment, dividends or strategic deals. Over a 2-6 month horizon this can tighten liquidity, increase reliance on external financing and constrain financial flexibility unless capex is normalized or operating cash rises.
Profitability volatility / EPS decline
A decline in EPS paired with fluctuating EBIT/EBITDA margins suggests inconsistent cost control or product-mix pressure. Such volatility hampers predictability of earnings, complicates capital allocation decisions and could erode investor confidence and reinvestment capacity if margin drivers are not stabilized.
Rising debt / liquidity monitoring
Even a modest uptick in total debt, combined with FCF variability, increases liquidity risk and reduces headroom for additional borrowing. This can elevate interest-cost exposure and force tighter capital discipline or asset sales under stress, weakening resilience to demand downturns or unexpected shocks.

Takara Holdings Inc. (2531) vs. iShares MSCI Japan ETF (EWJ)

Takara Holdings Inc. Business Overview & Revenue Model

Company DescriptionTakara Holdings Inc., together with its subsidiaries, primarily manufactures and sells alcoholic beverages, seasonings, and raw alcohol worldwide. The company offers shochu, sake, light-alcohol refreshers, seasonings, Japanese alcoholic beverages, and whisky; research reagents and scientific instruments; contract research services; and gene therapy commercialization services. It is involved in the import, export, and wholesale of alcoholic beverages, food products, seasonings, etc.; and printing, real estate leasing, marketing research, sales promotion planning, temporary staffing, transportation, warehousing, automobile service, non-life insurance agency, travel agent, etc. activities. In addition, the company engages in the wholesale of glass bottles; and sale of feed. Takara Holdings Inc. was founded in 1842 and is headquartered in Kyoto, Japan.
How the Company Makes MoneyTakara Holdings generates revenue through multiple streams, primarily from the sale of its diagnostic products, pharmaceuticals, and research reagents. The company markets its products to academic institutions, healthcare providers, and pharmaceutical companies, both domestically and internationally. Key revenue streams include sales of life science research tools such as DNA and RNA extraction kits, PCR reagents, and cell culture media. Additionally, Takara Holdings may engage in partnerships with other biotech firms and research institutions, contributing to its earnings through collaborative projects and licensing agreements. The company's focus on innovation and high-quality products helps maintain its competitive edge in the biotechnology market.

Takara Holdings Inc. Financial Statement Overview

Summary
Takara Holdings Inc. shows strong revenue growth and a robust balance sheet, but faces challenges in liquidity due to high capital expenditures. The income statement indicates operational efficiency, yet profitability and cash flow management need improvement.
Income Statement
76
Positive
Takara Holdings Inc. has demonstrated consistent revenue growth over the years, with a notable increase from 2021 to 2025. The gross profit margin and net profit margin have remained stable, indicating strong operational efficiency. However, the EBIT and EBITDA margins have shown some fluctuations, suggesting potential challenges in cost management. Overall, the company exhibits a solid income statement performance with room for improvement in profitability management.
Balance Sheet
82
Very Positive
The company maintains a robust balance sheet with a healthy equity ratio and a manageable debt-to-equity ratio. The increasing stockholders' equity and total assets over the years highlight financial stability and growth. However, the slight increase in total debt in recent years warrants cautious monitoring. Overall, the balance sheet reflects financial strength and stability with prudent leverage management.
Cash Flow
68
Positive
Takara Holdings Inc. has experienced variability in free cash flow, with a notable decline in recent years. Despite a strong operating cash flow, the negative free cash flow indicates high capital expenditures, which could affect liquidity. The operating cash flow to net income ratio suggests efficient cash generation, yet the company should focus on improving free cash flow management for better financial flexibility.
BreakdownTTMMar 2024Mar 2023Mar 2022Mar 2021Mar 2021
Income Statement
Total Revenue371.08B362.69B339.37B350.67B300.92B278.44B
Gross Profit123.19B119.65B113.93B119.94B113.54B115.59B
EBITDA38.04B38.59B37.87B48.06B50.59B29.86B
Net Income15.18B16.20B16.18B21.21B20.77B10.57B
Balance Sheet
Total Assets470.12B477.59B437.47B399.17B362.44B306.92B
Cash, Cash Equivalents and Short-Term Investments62.09B83.30B95.08B96.82B81.62B67.38B
Total Debt52.54B65.60B47.80B44.56B53.75B43.75B
Total Liabilities183.32B176.68B157.00B143.86B137.88B115.38B
Stockholders Equity233.90B245.23B228.67B203.95B180.42B156.88B
Cash Flow
Free Cash Flow0.00-3.99B9.97B34.86B1.61B13.19B
Operating Cash Flow0.0016.16B29.18B45.48B16.38B27.10B
Investing Cash Flow0.00-41.56B-19.99B-10.47B-10.40B-6.74B
Financing Cash Flow0.006.55B-13.45B-22.21B4.13B-1.51B

Takara Holdings Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1607.00
Price Trends
50DMA
1616.69
Negative
100DMA
1598.12
Positive
200DMA
1509.26
Positive
Market Momentum
MACD
3.47
Negative
RSI
51.43
Neutral
STOCH
77.88
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2531, the sentiment is Positive. The current price of 1607 is above the 20-day moving average (MA) of 1597.17, below the 50-day MA of 1616.69, and above the 200-day MA of 1509.26, indicating a neutral trend. The MACD of 3.47 indicates Negative momentum. The RSI at 51.43 is Neutral, neither overbought nor oversold. The STOCH value of 77.88 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:2531.

Takara Holdings Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
¥1.92T12.896.93%3.05%4.75%-24.33%
70
Outperform
¥1.47T16.466.97%2.42%1.26%-13.39%
63
Neutral
¥686.51B33.713.63%0.67%0.25%-58.68%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
61
Neutral
¥314.85B15.931.92%5.66%-25.08%
60
Neutral
¥2.54T19.476.47%3.23%0.86%0.55%
57
Neutral
¥295.04B23.868.17%1.49%4.14%9.91%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:2531
Takara Holdings Inc.
1,615.50
490.64
43.62%
JP:2502
Asahi Group Holdings
1,646.00
-207.36
-11.19%
JP:2593
ITO EN
2,887.50
-55.76
-1.89%
JP:2503
Kirin Holdings Company
2,562.50
550.36
27.35%
JP:2501
Sapporo Holdings
1,687.00
141.01
9.12%
JP:2587
Suntory Beverage & Food
4,668.00
-64.65
-1.37%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 12, 2025